558 related articles for article (PubMed ID: 9719121)
21. Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma.
Chan OS; Sze HC; Lee MC; Chan LL; Chang AT; Lee SW; Hung WM; Lee AW; Ng WT
Head Neck; 2017 Mar; 39(3):533-540. PubMed ID: 27898191
[TBL] [Abstract][Full Text] [Related]
22. Locally recurrent nasopharyngeal carcinoma: treatment results for patients with computed tomography assessment.
Chua DT; Sham JS; Kwong DL; Wei WI; Au GK; Choy D
Int J Radiat Oncol Biol Phys; 1998 May; 41(2):379-86. PubMed ID: 9607354
[TBL] [Abstract][Full Text] [Related]
23. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
24. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience.
Lee N; Xia P; Quivey JM; Sultanem K; Poon I; Akazawa C; Akazawa P; Weinberg V; Fu KK
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):12-22. PubMed ID: 12007936
[TBL] [Abstract][Full Text] [Related]
25. Linear accelerator-based stereotactic radiosurgery for limited, locally persistent, and recurrent nasopharyngeal carcinoma: efficacy and complications.
Chua DT; Sham JS; Kwong PW; Hung KN; Leung LH
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):177-83. PubMed ID: 12694836
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors of locoregionally recurrent nasopharyngeal carcinoma--a retrospective review of 182 cases.
Yang TS; Ng KT; Wang HM; Wang CH; Liaw CC; Lai GM
Am J Clin Oncol; 1996 Aug; 19(4):337-43. PubMed ID: 8677900
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant high-dose-rate brachytherapy after external beam radiotherapy in nasopharyngeal carcinoma.
Ozyar E; Yildz F; Akyol FH; Atahan IL
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):101-8. PubMed ID: 11777627
[TBL] [Abstract][Full Text] [Related]
28. A retrospective study of the role of intracavitary brachytherapy and prognostic factors determining local tumour control after primary radical radiotherapy in 903 non-disseminated nasopharyngeal carcinoma patients.
Teo PM; Kwan WH; Yu P; Lee WY; Leung SF; Choi P
Clin Oncol (R Coll Radiol); 1996; 8(3):160-6. PubMed ID: 8814370
[TBL] [Abstract][Full Text] [Related]
29. Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors.
Chyle V; Zagars GK; Wheeler JA; Wharton JT; Delclos L
Int J Radiat Oncol Biol Phys; 1996 Jul; 35(5):891-905. PubMed ID: 8751398
[TBL] [Abstract][Full Text] [Related]
30. Intensity-modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma.
Qiu S; Lin S; Tham IW; Pan J; Lu J; Lu JJ
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):676-83. PubMed ID: 22024207
[TBL] [Abstract][Full Text] [Related]
31. Brachytherapy for primary and recurrent nasopharyngeal carcinoma: 20 years' experience at Long Beach Memorial.
Syed AM; Puthawala AA; Damore SJ; Cherlow JM; Austin PA; Sposto R; Ramsinghani NS
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1311-21. PubMed ID: 10889385
[TBL] [Abstract][Full Text] [Related]
32. [Long-term efficacy of external radiotherapy plus intracavitary hyperfractionated brachytherapy on nasopharyngeal carcinoma].
Lin SJ; Pan JJ; Wu JX; Han L; Pan CZ
Ai Zheng; 2007 Feb; 26(2):208-11. PubMed ID: 17298755
[TBL] [Abstract][Full Text] [Related]
33. Brachytherapy boost in loco-regionally advanced nasopharyngeal carcinoma: a prospective randomized trial of the International Atomic Energy Agency.
Rosenblatt E; Abdel-Wahab M; El-Gantiry M; Elattar I; Bourque JM; Afiane M; Benjaafar N; Abubaker S; Chansilpa Y; Vikram B; Levendag P
Radiat Oncol; 2014 Mar; 9():67. PubMed ID: 24581393
[TBL] [Abstract][Full Text] [Related]
34. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
[TBL] [Abstract][Full Text] [Related]
35. Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy.
Hua YJ; Han F; Lu LX; Mai HQ; Guo X; Hong MH; Lu TX; Zhao C
Eur J Cancer; 2012 Dec; 48(18):3422-8. PubMed ID: 22835782
[TBL] [Abstract][Full Text] [Related]
36. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
37. Addition of intracavitary brachytherapy to external beam radiation therapy for T1-T2 nasopharyngeal carcinoma.
Wu J; Guo Q; Lu JJ; Zhang C; Zhang X; Pan J; Tham IW
Brachytherapy; 2013; 12(5):479-86. PubMed ID: 23466362
[TBL] [Abstract][Full Text] [Related]
38. Long-term survival and late complications in intensity-modulated radiotherapy of locally recurrent T1 to T2 nasopharyngeal carcinoma.
Tian YM; Guan Y; Xiao WW; Zeng L; Liu S; Lu TX; Zhao C; Han F
Head Neck; 2016 Feb; 38(2):225-31. PubMed ID: 25244494
[TBL] [Abstract][Full Text] [Related]
39. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy.
Teo PM; Chan AT; Lee WY; Leung TW; Johnson PJ
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):261-71. PubMed ID: 10030248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]